Rating History for Portola Pharmaceuticals (PTLA) by Citi
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/5/2020 | Yigal Nochomovitz | Downgrade | Neutral (Buy) |
18.00 (31.00) |
7.76 (18.03) |
132.35% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/5/2020 | Yigal Nochomovitz | Downgrade | Neutral (Buy) |
18.00 (31.00) |
7.76 (18.03) |
132.35% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||